Universal Ibogaine Inc.
IBOGF
$0.065
-$0.005-7.14%
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -286.09% | -7.51% | 24.06% | 43.89% | 38.92% |
| Total Depreciation and Amortization | -2.15% | -1.78% | -6.37% | 23.41% | 3.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,042.97% | 25.49% | -89.11% | 194.65% | -81.73% |
| Change in Net Operating Assets | -265.60% | 174.54% | -217.93% | -68.50% | 2,350.00% |
| Cash from Operations | -632.94% | 62.89% | -3,258.14% | 103.38% | 64.36% |
| Capital Expenditure | -108.82% | 69.64% | -181.45% | 187.03% | 79.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -108.82% | 69.64% | -181.45% | 187.03% | 79.80% |
| Total Debt Issued | -- | -- | -- | -114.13% | 92.89% |
| Total Debt Repaid | -1.24% | 15.67% | -33.92% | -597.56% | 76.30% |
| Issuance of Common Stock | 212.99% | 217.20% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10,337.50% | -- | -- | -- | -- |
| Cash from Financing | 121.08% | 359.69% | 173.58% | -122.23% | 108.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.65% | 234.31% | -278.52% | -125.06% | 131.32% |
